Using Best–Worst Scaling to Measure Caregiver Preferences for Managing their Child’s ADHD: A Pilot Study

Patient

Volumn 8, Issue 5, 2015, Pages 423-431

  dosReis, Susan ^a   Ng, Xinyi ^a   Frosch, Emily ^b   Reeves, Gloria ^c   Cunningham, Charles ^d   Bridges, John F P ^e  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BEST WORST SCALING INSTRUMENT; CAREGIVER; CHILD CARE; CLINICAL ASSESSMENT TOOL; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PEDIATRICIAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; SCORING SYSTEM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CONSUMER ATTITUDE; DECISION MAKING; ECONOMICS; EDUCATION; FAMILY; MARYLAND; PILOT STUDY; PSYCHOLOGY; RISK ASSESSMENT; SOCIAL SUPPORT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BALTIMORE; CAREGIVERS; CHILD; CHOICE BEHAVIOR; CONSUMER BEHAVIOR; EVIDENCE-BASED PRACTICE; FAMILY; HUMANS; PILOT PROJECTS; RISK ASSESSMENT; SOCIAL SUPPORT;

EID: 84942364126     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-014-0098-4     Document Type: Article

References (47)

1. Perou R, Bitsko RH, Blumberg SJ, Pastor P, Ghandour RM, Gfroerer JC, et al. Mental health surveillance among children—United States, 2005–2011. MMWR Surv Summ. 2013;62(Suppl 2):1–35.
2. Donfrancesco R, Marano A, Calderoni D, Mugnaini D, Thomas F, Di Trani M, et al. Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and Latium. Epidemiol Psychiatr Sci. 2014;15:1–9.
3. Parr JR, Ward A, Inman S. Current practice in the management of attention deficit disorder with hyperactivity (ADHD). Child Care Health Dev. 2003;29(3):215–8.
4. Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003;160(6):1071–7.
5. Olfson M, Marcus S, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 2002;41(5):514–21.
6. Zito JM, Safer DJ, dosReis S, Gardner JF, Magder L, Soeken K, et al. Psychotropic practice patterns for youth. A 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17–25.
7. Zito JM, Safer DJ, Riddle MA, Johnson RE, Speedie SM, Fox M. Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol. 1998;8(2):99–105.
8. Visser SN, Bitsko RH, Danielson ML, Perou R. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439–43.
9. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36(10 Suppl):85S–121S.
10. American Academy of Child and Adolescent Psychiatry. Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41(2 Suppl):26S–49S.
11. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–44.
12. The MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1088–96.
13. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073–86.
14. Ruel J, Hickey CP. Are too many children being treated with methylphenidate? Can J Psychiatry. 1992;37(8):570–2.
15. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, et al. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry. 1999;38(7):797–804.
16. Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, et al. Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics. 2011;127(6):1102–10.
17. Winterstein AG. Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies. Curr Psychiatry Rep. 2013;15(8):379.
18. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1304–13.
19. Hansen DL, Hansen EH. Caught in a balancing act: parents’ dilemmas regarding their ADHD child’s treatment with stimulant medication. Qual Health Res. 2006;16(9):1267–85.
20. McLeod JD, Fettes DL, Jensen PS, Pescosolido BA, Martin JK. Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. Psychiatr Serv. 2007;58(5):626–31.
21. dosReis S, Barksdale CL, Sherman A, Maloney K, Charach A. Stigmatizing experiences of parents of children newly diagnosed with ADHD. Psychiatr Serv. 2010;61(8):811–6.
22. dosReis S, Mychailyszyn MP, Evans-Lacko SE, Beltran A, Riley AW, Myers MA. The meaning of ADHD medication and parents’ initiation and continuity of treatment for their child. J Child Adolesc Psychopharmacol. 2009;19(4):377–83.
23. dosReis S, Mychailyszyn MP, Myers MA, Riley AW. Coming to terms with ADHD: how urban African–American families come to seek care for their children. Psychiatr Serv. 2007;58(5):636–41.
24. Leslie LK, Plemmons D, Monn AR, Palinkas LA. Investigating ADHD treatment trajectories: listening to families’ stories about medication use. J Dev Behav Pediatr. 2007;28(3):179–88.
25. Bussing R, Zima BT, Gary FA, Garvan CW. Barriers to detection, help-seeking, and service use for children with ADHD symptoms. J Behav Health Serv Res. 2003;30(2):176–89.
26. dosReis S, Butz A, Lipkin P, Anixt J, Weiner CL, Chernoff R. Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African–American families in an inner city community. J Behav Health Serv Res. 2006;33(4):423–30.
27. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559–67.
28. Swift JK, Callahan JL. The impact of client treatment preferences on outcome: a meta-analysis. J Clin Psychol. 2009;65(4):368–81.
29. Bussing R, Koro-Ljungberg ME, Gary F, Mason DM, Garvan CW. Exploring help-seeking for ADHD symptoms: a mixed-methods approach. Harv Rev Psychiatry. 2005;13(2):85–101.
30. dosReis S, Myers MA. Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model. Int Rev Psychiatry. 2008;20(2):135–41.
31. Fiks AG, Mayne S, Debartolo E, Power TJ, Guevara JP. Parental preferences and goals regarding ADHD treatment. Pediatrics. 2013;132(4):692–702.
32. Muhlbacher A, Rudolph I, Lincke H-J, Nubling M. Preferences for treatment of attention-deficit/hyperactivity disorder (ADHD): a discrete choice experiment. BMC Health Serv Res. 2009;9(1):149.
33. Muhlbacher AC, Nubling M. Analysis of patients’ preferences: direct assessment and discrete-choice experiment in therapy of adults with attention-deficit hyperactivity disorder. Patient. 2010;3(4):285–94.
34. Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United Kingdom. Med Decis Making. 2005;25(1):56–70.
35. Waschbusch DA, Cunningham CE, Pelham WE, Rimas HL, Greiner AR, Gnagy EM, et al. A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD. J Clin Child Adolesc Psychol. 2011;40(4):546–61.
36. Mullins CD, Abdulhalim AM, Lavallee DC. Continuous patient engagement in comparative effectiveness research. J Am Med Assoc. 2012;307(15):1587–8.
37. Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–13.
38. Coast J, Al-Janabi H, Sutton EJ, Horrocks SA, Vosper AJ, Swancutt DR, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–41.
39. Flynn TN. Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):259–67.
40. Flynn TN, Louviere JJ, Peters TJ, Coast J. Estimating preferences for a dermatology consultation using Best–Worst Scaling: comparison of various methods of analysis. BMC Med Res Methodol. 2008;8:76. http://www.biomedcentral.clm/1471-2288/8/76.
41. Louviere JJ, Flynn TN. Using best–worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in Australia. Patient. 2010;3(4):275–83.
42. Tsai P-W, Gilmour SG, Mead R. Some new three-leel orthogonal main effects plans robust to model uncertainty. Stat Sin. 2004;14:1075–84.
43. Gallego G, Bridges JF, Flynn T, Blauvelt BM, Niessen LW. Using best–worst scaling in horizon scanning for hepatocellular carcinoma technologies. Int J Technol Assess Health Care. 2012;28(3):339–46.
44. Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Pol Health. 1992;11(1):12–25.
45. Bussing R, Schoenberg NE, Perwien AR. Knowledge and information about ADHD: evidence of cultural differences among African–American and white parents. Soc Sci Med. 1998;46(7):919–28.
46. dosReis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW, Ellwood LC. Parental perceptions and satisfaction with stimulant medication for attention-deficit/hyperactivity disorder. J Dev Behav Pediatr. 2003;24(3):155–62.
47. Chronis AM, Chacko A, Fabiano GA, Wymbs BT, Pelham WE Jr. Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions. Clin Child Fam Psychol Rev. 2004;7(1):1–27.